Amgen Inc. (AMGN)

Last Closing Price: 289.33 (2025-06-20)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Amgen Inc. (AMGN) had Net Income of $1.73B for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$8.15B
Net Income
$1.73B
$2.97B
$5.18B
$6.97B
$1.18B
$795.00M
$1.97B
$1.97B
$1.73B
$1.73B
$1.73B
$1.73B
$1.18B
$3.37B
538.00M
541.00M
$3.22
$3.20
Balance Sheet Financials
$26.93B
$6.68B
$62.44B
$89.37B
$23.01B
$54.01B
$60.15B
$83.16B
$6.21B
$-38.16B
$6.21B
537.70M
Cash Flow Statement Financials
$1.39B
$-447.00M
$-4.11B
$11.97B
$8.81B
$-3.16B
$85.00M
$-1.28B
--
Fundamental Metrics & Ratios
1.17
--
--
0.90
9.24
63.58%
14.46%
14.46%
--
24.21%
21.23%
$980.00M
--
--
--
0.09
0.44
1.00
89.81
27.87%
-4.53%
1.94%
2.87%
$11.54
$1.81
$2.57